Kaufmann, Stefan H. E. Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;
Sun, R., Skeiky, Y. A. W., Izzo, A., Dheenadhayalan, V., Imam, Z., Penn, E., et al. (2009). Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Vaccine, 27(33), 4412-4423.